|Articles|November 3, 2014
So Who’s in Charge of Medicines in Brussels?
So now we know who is to do what on health issues in the new European Commission. Or do we?
Advertisement
So now we know who is to do what on health issues in the new European Commission. Or do we?
The furor that the new boss of the commission, Jean-Claude Juncker, unleashed with the plans for his new team, weeks before it took office, is still reverberating around Brussels. Peter O’ Donnell reports on the fallout in
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
3
Report: Richard Pazdur Out as Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
